DOCSLIB.ORG

C Supplement Table S4 Entrez Gene ID Symbol Gene Name Down

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
C Supplement Table S4 Entrez Gene ID Symbol Gene Name Down Supplement Table S4 Entrez Gene ID Symbol Gene name Down-regulated fold 1 53405 CLIC5 chloride intracellular channel 5 20.15 2 79625 C4orf31 chromosome 4 open reading frame 31 19.26 3 650 BMP2 bone morphogenetic protein 2 18.27 4 23109 DDN dendrin 17.68 5 259217 HSPA12A heat shock 70kDa protein 12A 17.54 6 51196 PLCE1 phospholipase C, epsilon 1 15.57 7 5800 PTPRO protein tyrosine phosphatase, receptor type, O 14.68 8 5730 PTGDS prostaglandin D2 synthase 21kDa (brain) 14.33 9 4311 MME membrane metallo-endopeptidase (neutral endopeptidase, enkep 14.01 10 2028 ENPEP glutamyl aminopeptidase (aminopeptidase A) 13.54 11 199 AIF1 allograft inflammatory factor 1 12.50 12 1286 COL4A4 collagen, type IV, alpha 4 11.21 13 23213 SULF1 sulfatase 1 10.48 14 22925 PLA2R1 phospholipase A2 receptor 1, 180kDa 10.40 15 5058 PAK1 p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast) 9.14 16 55752 SEPT11 septin 11 8.94 17 6943 TCF21 transcription factor 21 8.45 18 9863 MAGI2 membrane associated guanylate kinase, WW and PDZ domain c 8.22 19 7139 TNNT2 troponin T type 2 (cardiac) 8.19 20 2152 F3 coagulation factor III (thromboplastin, tissue factor) 7.83 21 5734 PTGER4 prostaglandin E receptor 4 (subtype EP4) 7.64 22 7422 VEGFA vascular endothelial growth factor A 7.52 23 10402 ST3GAL6 ST3 beta-galactoside alpha-2,3-sialyltransferase 6 7.19 24 7301 TYRO3 TYRO3 protein tyrosine kinase 6.98 25 2149 F2R coagulation factor II (thrombin) receptor 6.93 26 347 APOD apolipoprotein D 6.69 27 1490 CTGF connective tissue growth factor 6.58 28 23022 PALLD palladin, cytoskeletal associated protein 6.51 29 4189 DNAJB9 DnaJ (Hsp40) homolog, subfamily B, member 9 6.49 30 7490 WT1 Wilms tumor 1 6.42 31 7739 ZNF185 zinc finger protein 185 (LIM domain) 6.39 32 51232 CRIM1 cysteine rich transmembrane BMP regulator 1 (chordin-like) 6.23 33 1545 CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1 6.14 34 10602 CDC42EP3 CDC42 effector protein (Rho GTPase binding) 3 6.08 35 9636 ISG15 ISG15 ubiquitin-like modifier 6.01 36 221981 THSD7A thrombospondin, type I, domain containing 7A 6.00 37 4868 NPHS1 nephrosis 1, congenital, Finnish type (nephrin) 5.94 38 1285 COL4A3 collagen, type IV, alpha 3 (Goodpasture antigen) 5.85 39 2195 FAT FAT tumor suppressor homolog 1 (Drosophila) 5.82 40 9806 SPOCK2 sparc/osteonectin, cwcv and kazal-like domains proteoglycan (te 5.76 41 9037 SEMA5A sema domain, seven thrombospondin repeats (type 1 and type 1 5.48 42 3485 IGFBP2 insulin-like growth factor binding protein 2, 36kDa 5.36 43 5654 HTRA1 HtrA serine peptidase 1 5.30 44 3621 ING1 inhibitor of growth family, member 1 5.29 45 1028 CDKN1C cyclin-dependent kinase inhibitor 1C (p57, Kip2) 4.94 46 7049 TGFBR3 transforming growth factor, beta receptor III 4.81 47 4023 LPL lipoprotein lipase 4.77 48 10391 CORO2B coronin, actin binding protein, 2B 4.66 49 715 C1R complement component 1, r subcomponent 4.63 50 2697 GJA1 gap junction protein, alpha 1, 43kDa 4.47 51 716 C1S complement component 1, s subcomponent 4.36 52 25999 CLIP3 CAP-GLY domain containing linker protein 3 4.08 53 23114 NFASC neurofascin homolog (chicken) 4.05 54 23380 SRGAP2 SLIT-ROBO Rho GTPase activating protein 2 3.92 55 1605 DAG1 dystroglycan 1 (dystrophin-associated glycoprotein 1) 3.92 56 5653 KLK6 kallikrein-related peptidase 6 3.91 57 8556 CDC14A CDC14 cell division cycle 14 homolog A (S. cerevisiae) 3.91 58 10398 MYL9 myosin, light chain 9, regulatory 3.85 59 961 CD47 CD47 molecule 3.73 60 56941 C3orf37 chromosome 3 open reading frame 37 3.72 61 9435 CHST2 carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 3.71 62 3693 ITGB5 integrin, beta 5 3.68 63 7357 UGCG UDP-glucose ceramide glucosyltransferase 3.68 64 5352 PLOD2 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 3.64 65 1604 CD55 CD55 molecule, decay accelerating factor for complement (Crom 3.58 66 4638 MYLK myosin, light chain kinase 3.57 67 10217 CTDSPL CTD (carboxy-terminal domain, RNA polymerase II, polypeptide 3.54 68 868 CBLB Cas-Br-M (murine) ecotropic retroviral transforming sequence b 3.53 69 9748 SLK STE20-like kinase (yeast) 3.51 70 10521 DDX17 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 3.40 71 805 CALM2 calmodulin 2 (phosphorylase kinase, delta) 3.37 72 2920 CXCL2 chemokine (C-X-C motif) ligand 2 3.29 73 4170 MCL1 myeloid cell leukemia sequence 1 (BCL2-related) 3.17 74 29970 SCHIP1 schwannomin interacting protein 1 3.16 75 3675 ITGA3 integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 recep 3.01 76 1843 DUSP1 dual specificity phosphatase 1 2.89 77 4204 MECP2 methyl CpG binding protein 2 (Rett syndrome) 2.83 78 5420 PODXL podocalyxin-like 2.81 79 133 ADM adrenomedullin 2.79 80 2869 GRK5 G protein-coupled receptor kinase 5 2.79 81 10140 TOB1 transducer of ERBB2, 1 2.78 82 5054 SERPINE1 serpin peptidase inhibitor, clade E (nexin, plasminogen activator 2.76 83 8519 IFITM1 interferon induced transmembrane protein 1 (9-27) 2.71 84 8412 BCAR3 breast cancer anti-estrogen resistance 3 2.68 85 120 ADD3 adducin 3 (gamma) 2.65 86 23370 ARHGEF18 rho/rac guanine nucleotide exchange factor (GEF) 18 2.64 87 9788 MTSS1 metastasis suppressor 1 2.61 88 301 ANXA1 annexin A1 2.60 89 7091 TLE4 transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) 2.56 90 26471 NUPR1 nuclear protein 1 2.54 91 54587 MXRA8 matrix-remodelling associated 8 2.54 92 1647 GADD45A growth arrest and DNA-damage-inducible, alpha 2.52 93 7453 WARS tryptophanyl-tRNA synthetase 2.52 94 558 AXL AXL receptor tyrosine kinase 2.51 95 7073 TIAL1 TIA1 cytotoxic granule-associated RNA binding protein-like 1 2.51 96 11346 SYNPO synaptopodin 2.48 97 1595 CYP51A1 cytochrome P450, family 51, subfamily A, polypeptide 1 2.48 98 2534 FYN FYN oncogene related to SRC, FGR, YES 2.47 99 3320 HSP90AA1 heat shock protein 90kDa alpha (cytosolic), class A member 1 2.46 100 2316 FLNA filamin A, alpha (actin binding protein 280) 2.45 101 7431 VIM vimentin 2.45 102 10370 CITED2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-te 2.42 103 10631 POSTN periostin, osteoblast specific factor 2.41 104 56288 PARD3 par-3 partitioning defective 3 homolog (C. elegans) 2.40 105 9846 GAB2 GRB2-associated binding protein 2 2.39 106 23741 EID1 EP300 interacting inhibitor of differentiation 1 2.37 107 330 BIRC3 baculoviral IAP repeat-containing 3 2.36 108 4643 MYO1E myosin IE 2.33 109 1859 DYRK1A dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A 2.32 110 6595 SMARCA2 SWI/SNF related, matrix associated, actin dependent regulator o 2.32 111 84159 ARID5B AT rich interactive domain 5B (MRF1-like) 2.30 112 5516 PPP2CB protein phosphatase 2 (formerly 2A), catalytic subunit, beta isofo 2.28 113 3301 DNAJA1 DnaJ (Hsp40) homolog, subfamily A, member 1 2.27 114 9180 OSMR oncostatin M receptor 2.23 115 7290 HIRA HIR histone cell cycle regulation defective homolog A (S. cerevis 2.23 116 10096 ACTR3 ARP3 actin-related protein 3 homolog (yeast) 2.21 117 10627 MRCL3 myosin regulatory light chain MRCL3 2.21 118 10133 OPTN optineurin 2.20 119 5928 RBBP4 retinoblastoma binding protein 4 2.18 120 4059 BCAM basal cell adhesion molecule (Lutheran blood group) 2.15 121 28951 TRIB2 tribbles homolog 2 (Drosophila) 2.15 122 4664 NAB1 NGFI-A binding protein 1 (EGR1 binding protein 1) 2.14 123 3490 IGFBP7 insulin-like growth factor binding protein 7 2.08 124 71 ACTG1 actin, gamma 1 2.07 125 9231 DLG5 discs, large homolog 5 (Drosophila) 2.06 126 23048 FNBP1 formin binding protein 1 2.04 127 7534 YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activat 2.03 128 9778 KIAA0232 KIAA0232 gene product 1.80 129 7322 UBE2D2 ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast) 1.78.
Load more

Recommended publications
  • The RNA Response to DNA Damage
    ÔØ ÅÒÙ×Ö ÔØ The RNA response to DNA damage Luciana E. Giono, Nicol´as Nieto Moreno, Adri´an E. Cambindo Botto, Gwendal Dujardin, Manuel J. Mu˜noz, Alberto R. Kornblihtt PII: S0022-2836(16)00177-7 DOI: doi: 10.1016/j.jmb.2016.03.004 Reference: YJMBI 65022 To appear in: Journal of Molecular Biology Received date: 10 December 2015 Revised date: 1 March 2016 Accepted date: 7 March 2016 Please cite this article as: Giono, L.E., Moreno, N.N., Botto, A.E.C., Dujardin, G., Mu˜noz, M.J. & Kornblihtt, A.R., The RNA response to DNA damage, Journal of Molec- ular Biology (2016), doi: 10.1016/j.jmb.2016.03.004 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. ACCEPTED MANUSCRIPT The RNA response to DNA damage Luciana E. Giono1, Nicolás Nieto Moreno1, Adrián E. Cambindo Botto1, Gwendal Dujardin1,2, Manuel J. Muñoz1, and Alberto R. Kornblihtt1* 1Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE-UBA-CONICET) and Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón 2, C1428EHA Buenos Aires, Argentina 2Centre for GenomicACCEPTED Regulation. Dr.
    [Show full text]
  • The Rise and Fall of the Bovine Corpus Luteum
    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Spring 5-6-2017 The Rise and Fall of the Bovine Corpus Luteum Heather Talbott University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Biochemistry Commons, Molecular Biology Commons, and the Obstetrics and Gynecology Commons Recommended Citation Talbott, Heather, "The Rise and Fall of the Bovine Corpus Luteum" (2017). Theses & Dissertations. 207. https://digitalcommons.unmc.edu/etd/207 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. THE RISE AND FALL OF THE BOVINE CORPUS LUTEUM by Heather Talbott A DISSERTATION Presented to the Faculty of the University of Nebraska Graduate College in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Biochemistry and Molecular Biology Graduate Program Under the Supervision of Professor John S. Davis University of Nebraska Medical Center Omaha, Nebraska May, 2017 Supervisory Committee: Carol A. Casey, Ph.D. Andrea S. Cupp, Ph.D. Parmender P. Mehta, Ph.D. Justin L. Mott, Ph.D. i ACKNOWLEDGEMENTS This dissertation was supported by the Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA) Pre-doctoral award; University of Nebraska Medical Center Graduate Student Assistantship; University of Nebraska Medical Center Exceptional Incoming Graduate Student Award; the VA Nebraska-Western Iowa Health Care System Department of Veterans Affairs; and The Olson Center for Women’s Health, Department of Obstetrics and Gynecology, Nebraska Medical Center.
    [Show full text]
  • Dedifferentiation by Adenovirus E1A Due to Inactivation of Hippo Pathway Effectors YAP and TAZ
    Downloaded from genesdev.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press Dedifferentiation by adenovirus E1A due to inactivation of Hippo pathway effectors YAP and TAZ Nathan R. Zemke, Dawei Gou, and Arnold J. Berk Molecular Biology Institute, University of California at Los Angeles, Los Angeles, California 90095, USA Adenovirus transformed cells have a dedifferentiated phenotype. Eliminating E1A in transformed human embryonic kidney cells derepressed ∼2600 genes, generating a gene expression profile closely resembling mesenchymal stem cells (MSCs). This was associated with a dramatic change in cell morphology from one with scant cytoplasm and a globular nucleus to one with increased cytoplasm, extensive actin stress fibers, and actomyosin-dependent flat- tening against the substratum. E1A-induced hypoacetylation at histone H3 Lys27 and Lys18 (H3K27/18) was reversed. Most of the increase in H3K27/18ac was in enhancers near TEAD transcription factors bound by Hippo signaling-regulated coactivators YAP and TAZ. E1A causes YAP/TAZ cytoplasmic sequestration. After eliminating E1A, YAP/TAZ were transported into nuclei, where they associated with poised enhancers with DNA-bound TEAD4 and H3K4me1. This activation of YAP/TAZ required RHO family GTPase signaling and caused histone acetylation by p300/CBP, chromatin remodeling, and cohesin loading to establish MSC-associated enhancers and then superenhancers. Consistent results were also observed in primary rat embryo kidney cells, human fibroblasts, and human respiratory tract epithelial cells. These results together with earlier studies suggest that YAP/TAZ function in a developmental checkpoint controlled by signaling from the actin cytoskeleton that prevents differ- entiation of a progenitor cell until it is in the correct cellular and tissue environment.
    [Show full text]
  • Mouse Mxra8 Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Mxra8 Knockout Project (CRISPR/Cas9) Objective: To create a Mxra8 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Mxra8 gene (NCBI Reference Sequence: NM_024263 ; Ensembl: ENSMUSG00000029070 ) is located on Mouse chromosome 4. 10 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 10 (Transcript: ENSMUST00000030947). Exon 1~10 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Phenotypic analysis of mice homozygous for a gene trap allele indicates this mutation has no notable phenotype in any parameter tested in a high-throughput screen. Exon 1 starts from about 0.08% of the coding region. Exon 1~10 covers 100.0% of the coding region. The size of effective KO region: ~3486 bp. The KO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 6 7 8 9 10 Legends Exon of mouse Mxra8 Knockout region Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of start codon is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis.
    [Show full text]
  • Regulation of Cdc42 and Its Effectors in Epithelial Morphogenesis Franck Pichaud1,2,*, Rhian F
    © 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs217869. doi:10.1242/jcs.217869 REVIEW SUBJECT COLLECTION: ADHESION Regulation of Cdc42 and its effectors in epithelial morphogenesis Franck Pichaud1,2,*, Rhian F. Walther1 and Francisca Nunes de Almeida1 ABSTRACT An overview of Cdc42 Cdc42 – a member of the small Rho GTPase family – regulates cell Cdc42 was discovered in yeast and belongs to a large family of small – polarity across organisms from yeast to humans. It is an essential (20 30 kDa) GTP-binding proteins (Adams et al., 1990; Johnson regulator of polarized morphogenesis in epithelial cells, through and Pringle, 1990). It is part of the Ras-homologous Rho subfamily coordination of apical membrane morphogenesis, lumen formation and of GTPases, of which there are 20 members in humans, including junction maturation. In parallel, work in yeast and Caenorhabditis elegans the RhoA and Rac GTPases, (Hall, 2012). Rho, Rac and Cdc42 has provided important clues as to how this molecular switch can homologues are found in all eukaryotes, except for plants, which do generate and regulate polarity through localized activation or inhibition, not have a clear homologue for Cdc42. Together, the function of and cytoskeleton regulation. Recent studies have revealed how Rho GTPases influences most, if not all, cellular processes. important and complex these regulations can be during epithelial In the early 1990s, seminal work from Alan Hall and his morphogenesis. This complexity is mirrored by the fact that Cdc42 can collaborators identified Rho, Rac and Cdc42 as main regulators of exert its function through many effector proteins.
    [Show full text]
  • New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene Ontology
    Cancer Research and Treatment 2003;35(4):304-313 New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene Ontology Yong-Wan Kim, Ph.D.1, Min-Je Suh, M.S.1, Jin-Sik Bae, M.S.1, Su Mi Bae, M.S.1, Joo Hee Yoon, M.D.2, Soo Young Hur, M.D.2, Jae Hoon Kim, M.D.2, Duck Young Ro, M.D.2, Joon Mo Lee, M.D.2, Sung Eun Namkoong, M.D.2, Chong Kook Kim, Ph.D.3 and Woong Shick Ahn, M.D.2 1Catholic Research Institutes of Medical Science, 2Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul; 3College of Pharmacy, Seoul National University, Seoul, Korea Purpose: This study utilized both mRNA differential significant genes of unknown function affected by the display and the Gene Ontology (GO) analysis to char- HPV-16-derived pathway. The GO analysis suggested that acterize the multiple interactions of a number of genes the cervical cancer cells underwent repression of the with gene expression profiles involved in the HPV-16- cancer-specific cell adhesive properties. Also, genes induced cervical carcinogenesis. belonging to DNA metabolism, such as DNA repair and Materials and Methods: mRNA differential displays, replication, were strongly down-regulated, whereas sig- with HPV-16 positive cervical cancer cell line (SiHa), and nificant increases were shown in the protein degradation normal human keratinocyte cell line (HaCaT) as a con- and synthesis. trol, were used. Each human gene has several biological Conclusion: The GO analysis can overcome the com- functions in the Gene Ontology; therefore, several func- plexity of the gene expression profile of the HPV-16- tions of each gene were chosen to establish a powerful associated pathway, identify several cancer-specific cel- cervical carcinogenesis pathway.
    [Show full text]
  • Autism Multiplex Family with 16P11.2P12.2 Microduplication Syndrome in Monozygotic Twins and Distal 16P11.2 Deletion in Their Brother
    European Journal of Human Genetics (2012) 20, 540–546 & 2012 Macmillan Publishers Limited All rights reserved 1018-4813/12 www.nature.com/ejhg ARTICLE Autism multiplex family with 16p11.2p12.2 microduplication syndrome in monozygotic twins and distal 16p11.2 deletion in their brother Anne-Claude Tabet1,2,3,4, Marion Pilorge2,3,4, Richard Delorme5,6,Fre´de´rique Amsellem5,6, Jean-Marc Pinard7, Marion Leboyer6,8,9, Alain Verloes10, Brigitte Benzacken1,11,12 and Catalina Betancur*,2,3,4 The pericentromeric region of chromosome 16p is rich in segmental duplications that predispose to rearrangements through non-allelic homologous recombination. Several recurrent copy number variations have been described recently in chromosome 16p. 16p11.2 rearrangements (29.5–30.1 Mb) are associated with autism, intellectual disability (ID) and other neurodevelopmental disorders. Another recognizable but less common microdeletion syndrome in 16p11.2p12.2 (21.4 to 28.5–30.1 Mb) has been described in six individuals with ID, whereas apparently reciprocal duplications, studied by standard cytogenetic and fluorescence in situ hybridization techniques, have been reported in three patients with autism spectrum disorders. Here, we report a multiplex family with three boys affected with autism, including two monozygotic twins carrying a de novo 16p11.2p12.2 duplication of 8.95 Mb (21.28–30.23 Mb) characterized by single-nucleotide polymorphism array, encompassing both the 16p11.2 and 16p11.2p12.2 regions. The twins exhibited autism, severe ID, and dysmorphic features, including a triangular face, deep-set eyes, large and prominent nasal bridge, and tall, slender build. The eldest brother presented with autism, mild ID, early-onset obesity and normal craniofacial features, and carried a smaller, overlapping 16p11.2 microdeletion of 847 kb (28.40–29.25 Mb), inherited from his apparently healthy father.
    [Show full text]
  • Expressed Sequence Tag Analysis of the Response of Apple
    Physiologia Plantarum 133: 298–317. 2008 Copyright ª Physiologia Plantarum 2008, ISSN 0031-9317 Expressed sequence tag analysis of the response of apple (Malus x domestica ‘Royal Gala’) to low temperature and water deficit Michael Wisniewskia,*, Carole Bassetta,*, John Norellia, Dumitru Macarisina, Timothy Artlipa, Ksenija Gasicb and Schuyler Korbanb aUnited States Department of Agriculture – Agricultural Research Service (USDA-ARS), Appalachian Fruit Research Station, 2217 Wiltshire Road, Kearneysville, WV 25430, USA bDepartment of Natural Resources and Environmental Sciences, University of Illinois, 310 ERML, 1201 W. Gregory Drive, Urbana, IL 61801, USA Correspondence Leaf, bark, xylem and root tissues were used to make nine cDNA libraries from *Corresponding author, non-stressed (control) ‘Royal Gala’ apple trees, and from ‘Royal Gala’ trees e-mail: [email protected]; exposed to either low temperature (5°C for 24 h) or water deficit (45% of [email protected] saturated pot mass for 2 weeks). Over 22 600 clones from the nine libraries # Received 26 September 2007; revised 3 were subjected to 5 single-pass sequencing, clustered and annotated using January 2008 BLASTX. The number of clusters in the libraries ranged from 170 to 1430. Regarding annotation of the sequences, BLASTX analysis indicated that within doi: 10.1111/j.1399-3054.2008.01063.x the libraries 65–72% of the clones had a high similarity to known function genes, 6–15% had no functional assignment and 15–26% were completely novel. The expressed sequence tags were combined into three classes (control, low-temperature and water deficit) and the annotated genes in each class were placed into 1 of 10 different functional categories.
    [Show full text]
  • ARID5B As a Critical Downstream Target of the TAL1 Complex That Activates the Oncogenic Transcriptional Program and Promotes T-Cell Leukemogenesis
    Downloaded from genesdev.cshlp.org on October 10, 2021 - Published by Cold Spring Harbor Laboratory Press ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis Wei Zhong Leong,1 Shi Hao Tan,1 Phuong Cao Thi Ngoc,1 Stella Amanda,1 Alice Wei Yee Yam,1 Wei-Siang Liau,1 Zhiyuan Gong,2 Lee N. Lawton,1 Daniel G. Tenen,1,3,4 and Takaomi Sanda1,4 1Cancer Science Institute of Singapore, National University of Singapore, 117599 Singapore; 2Department of Biological Sciences, National University of Singapore, 117543 Singapore; 3Harvard Medical School, Boston, Massachusetts 02215, USA; 4Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 117599 Singapore The oncogenic transcription factor TAL1/SCL induces an aberrant transcriptional program in T-cell acute lym- phoblastic leukemia (T-ALL) cells. However, the critical factors that are directly activated by TAL1 and contribute to T-ALL pathogenesis are largely unknown. Here, we identified AT-rich interactive domain 5B (ARID5B) as a col- laborating oncogenic factor involved in the transcriptional program in T-ALL. ARID5B expression is down-regulated at the double-negative 2–4 stages in normal thymocytes, while it is induced by the TAL1 complex in human T-ALL cells. The enhancer located 135 kb upstream of the ARID5B gene locus is activated under a superenhancer in T-ALL cells but not in normal T cells. Notably, ARID5B-bound regions are associated predominantly with active tran- scription. ARID5B and TAL1 frequently co-occupy target genes and coordinately control their expression.
    [Show full text]
  • Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights Into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle
    animals Article Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle Masoumeh Naserkheil 1 , Abolfazl Bahrami 1 , Deukhwan Lee 2,* and Hossein Mehrban 3 1 Department of Animal Science, University College of Agriculture and Natural Resources, University of Tehran, Karaj 77871-31587, Iran; [email protected] (M.N.); [email protected] (A.B.) 2 Department of Animal Life and Environment Sciences, Hankyong National University, Jungang-ro 327, Anseong-si, Gyeonggi-do 17579, Korea 3 Department of Animal Science, Shahrekord University, Shahrekord 88186-34141, Iran; [email protected] * Correspondence: [email protected]; Tel.: +82-31-670-5091 Received: 25 August 2020; Accepted: 6 October 2020; Published: 9 October 2020 Simple Summary: Hanwoo is an indigenous cattle breed in Korea and popular for meat production owing to its rapid growth and high-quality meat. Its yearling weight and carcass traits (backfat thickness, carcass weight, eye muscle area, and marbling score) are economically important for the selection of young and proven bulls. In recent decades, the advent of high throughput genotyping technologies has made it possible to perform genome-wide association studies (GWAS) for the detection of genomic regions associated with traits of economic interest in different species. In this study, we conducted a weighted single-step genome-wide association study which combines all genotypes, phenotypes and pedigree data in one step (ssGBLUP). It allows for the use of all SNPs simultaneously along with all phenotypes from genotyped and ungenotyped animals. Our results revealed 33 relevant genomic regions related to the traits of interest.
    [Show full text]
  • Datasheet: VMA00210 Product Details
    Datasheet: VMA00210 Description: MOUSE ANTI NAB1 Specificity: NAB1 Format: Purified Product Type: PrecisionAb™ Monoclonal Clone: OTI1D2 Isotype: IgG1 Quantity: 100 µl Product Details Applications This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit www.bio-rad-antibodies.com/protocols. Yes No Not Determined Suggested Dilution Western Blotting 1/1000 PrecisionAb antibodies have been extensively validated for the western blot application. The antibody has been validated at the suggested dilution. Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Further optimization may be required dependant on sample type. Target Species Human Product Form Purified IgG - liquid Preparation Mouse monoclonal antibody purified by affinity chromatography from ascites Buffer Solution Phosphate buffered saline Preservative 0.09% Sodium Azide (NaN3) Stabilisers 1% Bovine Serum Albumin 50% Glycerol Immunogen Recombinant protein corresponding to amino acids 237-487 of human NAB1 (NP_005957) produced in E. coli External Database UniProt: Links Q13506 Related reagents Entrez Gene: 4664 NAB1 Related reagents Specificity Mouse anti Human NAB1 antibody recognizes the NGFI-A-binding protein 1, also known as Page 1 of 2 EGR-1-binding protein 1, EGR1 binding protein 1 and transcriptional regulatory protein p54. Mouse anti Human NAB1 antibody detects a band of 54 kDa. The antibody has been extensively validated for western blotting using whole cell lysates. Western Blotting Anti NAB1 detects a band of approximately 54 kDa in Jurkat cell lysates Instructions For Use Please refer to the PrecisionAb western blotting protocol.
    [Show full text]
  • Mutational Landscape Differences Between Young-Onset and Older-Onset Breast Cancer Patients Nicole E
    Mealey et al. BMC Cancer (2020) 20:212 https://doi.org/10.1186/s12885-020-6684-z RESEARCH ARTICLE Open Access Mutational landscape differences between young-onset and older-onset breast cancer patients Nicole E. Mealey1 , Dylan E. O’Sullivan2 , Joy Pader3 , Yibing Ruan3 , Edwin Wang4 , May Lynn Quan1,5,6 and Darren R. Brenner1,3,5* Abstract Background: The incidence of breast cancer among young women (aged ≤40 years) has increased in North America and Europe. Fewer than 10% of cases among young women are attributable to inherited BRCA1 or BRCA2 mutations, suggesting an important role for somatic mutations. This study investigated genomic differences between young- and older-onset breast tumours. Methods: In this study we characterized the mutational landscape of 89 young-onset breast tumours (≤40 years) and examined differences with 949 older-onset tumours (> 40 years) using data from The Cancer Genome Atlas. We examined mutated genes, mutational load, and types of mutations. We used complementary R packages “deconstructSigs” and “SomaticSignatures” to extract mutational signatures. A recursively partitioned mixture model was used to identify whether combinations of mutational signatures were related to age of onset. Results: Older patients had a higher proportion of mutations in PIK3CA, CDH1, and MAP3K1 genes, while young- onset patients had a higher proportion of mutations in GATA3 and CTNNB1. Mutational load was lower for young- onset tumours, and a higher proportion of these mutations were C > A mutations, but a lower proportion were C > T mutations compared to older-onset tumours. The most common mutational signatures identified in both age groups were signatures 1 and 3 from the COSMIC database.
    [Show full text]